Implementation of a Prostate SBRT Program in the Community Setting

Conventionally fractionated external beam radiation therapy (EBRT) has a long-standing track record of safety and excellent treatment outcomes in the management of all prostate cancer risk groups. With modern external beam radiation therapy techniques such as stereotactic body radiation therapy (SBRT), prostate cancer patients can now be treated safely with just a few fractions. SBRT is cost-effective and easy to implement in academic centers. With the recently announced PACE B primary outcome – that ultra-hypofractionated radiotherapy is non-inferior to standard radiotherapy for patients with low- and favorable intermediate-risk cancer, we expect that adoption of this regimen will accelerate further. Ultimately, whether SBRT can replace conventionally fractionated EBRT in the community is not known but it is the topic of this activity. This activity guides the community practitioner in developing their own prostate SBRT practice. The activity begins with a discussion around the evidence supporting 5-fraction prostate SBRT. Next, we provide some guidance regarding practice management. The third speaker discusses how to safely deliver ultra-hypofractionated radiation in the community. 

Topics:

  1. Evidence that SBRT is a New Standard of Care for Localized Prostate Cancer
    Nicholas van As, MD, MB
  2. Building a Successful Community Prostate SBRT Practice
    Jonathan Andrew Haas, MD
  3. The Safe Delivery of Prostate SBRT in the Community Setting
    Michael J. Zelefsky, MD, FASTRO
  4. Q and A
    Sean Philip Collins, MD - Moderator
    Full Panel

This activity is available from March 18, 2025, through 11:59 p.m. Eastern time on March 17, 2027. 

The content was originally presented and recorded at the 2024 ASTRO Annual Meeting.

Target Audience

The activity is designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, radiation therapists, radiation dosimetrists, residents and urologists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Be aware of the motivation and evidence for treating suitable prostate patients with SBRT.
  • Feel confident in contouring, treatment planning and delivery of prostate SBRT. Be cognizant of tips to reducing side effects. 
  • Be familiar with approaches to building a successful community prostate SBRT program including advice on successful team building, marketing and reimbursement.
Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
Course opens: 
03/18/2025
Course expires: 
03/17/2027
Cost:
$149.00
Rating: 
0
  • Sean Philip Collins, MD, PhD, is employed by University of South Florida. Dr. Collins receives honoraria from Accuray. 
  • Nicholas van As, MD, MB, is employed by The Royal Marsden NHS Foundation Trust. Dr. van As receives grant/research funding from Accuray and Varian.
  • Jonathan Andrew Haas, MD, is employed by Perlmutter Cancer Center at New York University Langone Hospital - Long Island. Dr. Haas receives honoraria from Accuray.
  • Michael J. Zelefsky, MD, FASTRO, is employed by NYU Langone Medical Center. Dr. Zelefsky was previously employed by Memorial Sloan Kettering Cancer Center (relationship ended on 4/1/2024). Dr. Zelefsky receives compensation/payment from Boston Scientific. Dr. Zelefsky serves as Editor-in-Chief of the Brachytherapy Journal. 

The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.

Disclosure link: 
ASTRO Education Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.

  • Nonmember: $149
  • Member: $99
  • Member-in-Training: $49
  • Student/Graduate Student/PGY-1 Member: $49
  • Postdoctoral Fellow Member: $49

If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date. 

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until March 17, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date. 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.